AnaptysBio (ANAB) Q1 2024 Earnings Report
MX:ANAB Q1 2024 EPS Results
- Actual EPS
- -MXN 20.54
- Consensus EPS
- -MXN 19.62
- Beat/Miss
- Missed by -MXN 0.92
- One Year Ago EPS
- -MXN 19.79
MX:ANAB Q1 2024 Revenue Results
- Actual Revenue
- MXN 134.91M
- Expected Revenue
- MXN 75.19M
- Beat/Miss
- Beat by +MXN 59.72M
- YoY Revenue Growth
- +422.49%
Earnings Announcement Details
- Quarter
- Q1 2024
- Date
- 05/09/2024
- Time
- After Close
- Conference Call
- Thursday, May 9, 2024
MX:ANAB Upcoming Earnings
AnaptysBio's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q1 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ANAB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -34.58-34.58 | 9.79 | -453.17% (-44.37) | ― |
| Sep 21, 2026 | 2026 (Q2) | -16.78-16.78 | -16.78 | 0.00% (+0.00) | |
| May 12, 2026 | 2026 (Q1) | 6.52-16.03 | -24.11 | 33.52% (+8.08) | |
| Mar 03, 2026 | 2025 (Q4) | -16.7829.75 | -9.02 | 429.79% (+38.77) | |
| Nov 04, 2025 | 2025 (Q3) | -16.039.79 | -14.28 | 168.55% (+24.07) | |
| Aug 06, 2025 | 2025 (Q2) | -9.02-25.20 | -21.42 | -17.63% (-3.78) | |
| May 05, 2025 | 2025 (Q1) | -14.28-24.11 | -20.54 | -17.38% (-3.57) | |
| Feb 27, 2025 | 2024 (Q4) | -20.28-9.02 | -19.92 | 54.72% (+10.90) | |
| Nov 05, 2024 | 2024 (Q3) | -20.63-14.28 | -17.66 | 19.15% (+3.38) | |
| Aug 05, 2024 | 2024 (Q2) | -13.04-21.42 | -18.79 | -14.00% (-2.63) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
